Health Care & Life Sciences » Pharmaceuticals | Samjin Pharmaceutical Co. Ltd.

Samjin Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,878
20,717
27,043
30,174
35,796
25,526
Depreciation, Depletion & Amortization
5,359
6,104
6,542
6,922
6,634
6,257
Other Funds
92
62
375
471
34
8,770
Funds from Operations
15,933
33,719
40,179
48,113
48,162
40,553
Changes in Working Capital
8,559
1,313
21,243
545
10,878
10,472
Net Operating Cash Flow
7,374
32,406
18,936
48,658
37,284
30,082
Capital Expenditures
6,864
14,393
8,828
7,912
9,173
Sale of Fixed Assets & Businesses
31
127
18
17
25
Purchase/Sale of Investments
1,876
1,392
1,331
2,632
224
Net Investing Cash Flow
5,109
12,874
10,141
10,634
8,587
Cash Dividends Paid - Total
3,812
4,981
6,226
7,472
8,717
Issuance/Reduction of Debt, Net
4,500
14,500
4,000
20,000
5,000
Net Financing Cash Flow
2,176
19,419
10,601
27,001
18,691
Net Change in Cash
89
114
1,806
11,023
10,005
Free Cash Flow
548
19,058
11,274
40,858
28,224
Other Sources
10
-
-
65
337
Change in Capital Stock
2,957
-
-
-
4,940
Other Uses
161
-
-
172
-

About Samjin Pharmaceutical Co.

View Profile
Address
121 Wausan-ro
Seoul SL 04054
Korea, Republic Of
Employees -
Website http://www.samjinpharm.co.kr
Updated 07/08/2019
Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. Its products include tablets, capsules, and shots. The company was founded on April 18, 1968 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.